Bekaii-Saab T - Search Results

1

A Comprehensive Review of Sequencing and Combination Strategies of Targeted Agents in Metastatic Colorectal Cancer.

Ciombor KK, Bekaii-Saab T. Ciombor KK, et al. Oncologist. 2018 Jan;23(1):25-34. doi: 10.1634/theoncologist.2017-0203. Epub 2017 Oct 11. Oncologist. 2018. PMID: 29021377 Free PMC article. Review.

2

KRAS testing in metastatic colorectal cancer: implications on the use of biologic agents.

Bekaii-Saab T. Bekaii-Saab T. Clin Colorectal Cancer. 2009 Jul;8(3):135-40. doi: 10.3816/CCC.2009.n.022. Clin Colorectal Cancer. 2009. PMID: 19632927 Review.

3

Influence of KRAS mutation status in metachronous and synchronous metastatic colorectal adenocarcinoma.

Rose JS, Serna DS, Martin LK, Li X, Weatherby LM, Abdel-Misih S, Zhao W, Bekaii-Saab T. Rose JS, et al. Cancer. 2012 Dec 15;118(24):6243-52. doi: 10.1002/cncr.27666. Epub 2012 Jun 6. Cancer. 2012. PMID: 22674181 Free PMC article.

4

Treatment patterns and clinical outcomes in patients with metastatic colorectal cancer initially treated with FOLFOX-bevacizumab or FOLFIRI-bevacizumab: results from ARIES, a bevacizumab observational cohort study.

Bendell JC, Bekaii-Saab TS, Cohn AL, Hurwitz HI, Kozloff M, Tezcan H, Roach N, Mun Y, Fish S, Flick ED, Dalal D, Grothey A. Bendell JC, et al. Oncologist. 2012;17(12):1486-95. doi: 10.1634/theoncologist.2012-0190. Epub 2012 Sep 26. Oncologist. 2012. PMID: 23015662 Free PMC article.

5

FOLFIRINOX in locally advanced pancreas adenocarcinoma: back to the future?

Bekaii-Saab T, Goldberg RM. Bekaii-Saab T, et al. Oncologist. 2013;18(5):487-9. doi: 10.1634/theoncologist.2013-0157. Oncologist. 2013. PMID: 23704222 Free PMC article. No abstract available.

6

Emerging treatments in recurrent and metastatic colorectal cancer.

Ciombor KK, Bekaii-Saab T. Ciombor KK, et al. J Natl Compr Canc Netw. 2013 Sep;11 Suppl 4(Suppl 4):S18-27. doi: 10.6004/jnccn.2013.0217. J Natl Compr Canc Netw. 2013. PMID: 24158967 Free PMC article. Review.

7

Seeing the forest through the trees: a systematic review of the safety and efficacy of combination chemotherapies used in the treatment of metastatic colorectal cancer.

Bekaii-Saab T, Wu C. Bekaii-Saab T, et al. Crit Rev Oncol Hematol. 2014 Jul;91(1):9-34. doi: 10.1016/j.critrevonc.2014.01.001. Epub 2014 Jan 15. Crit Rev Oncol Hematol. 2014. PMID: 24534706 Review.

8

Safety and effectiveness of bevacizumab treatment for metastatic colorectal cancer: final results from the Avastin(®) Registry - Investigation of Effectiveness and Safety (ARIES) observational cohort study.

Hurwitz HI, Bekaii-Saab TS, Bendell JC, Cohn AL, Kozloff M, Roach N, Mun Y, Fish S, Flick ED, Grothey A; ARIES Study Investigators. Hurwitz HI, et al. Clin Oncol (R Coll Radiol). 2014 Jun;26(6):323-32. doi: 10.1016/j.clon.2014.03.001. Epub 2014 Mar 28. Clin Oncol (R Coll Radiol). 2014. PMID: 24686090

9

Selumetinib for the treatment of cancer.

Ciombor KK, Bekaii-Saab T. Ciombor KK, et al. Expert Opin Investig Drugs. 2015 Jan;24(1):111-123. doi: 10.1517/13543784.2015.982275. Epub 2014 Nov 11. Expert Opin Investig Drugs. 2015. PMID: 25385055

10

Upfront molecular testing in patients with advanced gastro-esophageal cancer: Is it time yet?

Mikhail S, Ciombor K, Noonan A, Wu C, Goldberg R, Zhao W, Wei L, Mathey K, Yereb M, Timmers C, Bekaii-Saab T. Mikhail S, et al. Oncotarget. 2015 Sep 8;6(26):22206-13. doi: 10.18632/oncotarget.4247. Oncotarget. 2015. PMID: 26082439 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

393 results

Search Page

Filters